METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE

Clinical trials for METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE explained in plain language.

Never miss a new study

Get alerted when new METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE trials appear

Sign up with your email to follow new studies for METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Weight-Loss drug trial aims to curb drinking and heal livers

Disease control Not yet recruiting

This study is testing whether a medication called tirzepatide, currently used for weight management, can help people who struggle with heavy alcohol use and the related liver damage it causes. About 120 adults with alcohol use disorder and a specific type of metabolic liver disea…

Matched conditions: METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE

Phase: PHASE2 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE

Get alerted when new METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE trials appear

Weight-Loss drug trial aims to curb drinking and heal livers